Regulatory T cells in human autoimmune diseases

Springer Seminars in Immunopathology

Volumn 28, Issue 1, 2006, Pages 63-76

  Torgerson, Troy R ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3;

ANTIBODY SPECIFICITY; ATOPIC DERMATITIS; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; AUTOIMMUNITY; CELL PROLIFERATION; COMPLEMENT DEFICIENCY; ENTERITIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE RHEUMATOID ARTHRITIS; MULTIPLE ENDOCRINE ADENOMATOSIS; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; OMENN SYNDROME; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE SUBPOPULATION; VASCULITIS;

ANIMALS; AUTOIMMUNE DISEASES; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNE TOLERANCE; MICE; MUTATION; T-LYMPHOCYTES, REGULATORY;

EID: 33747602533     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00281-006-0041-4     Document Type: Review

References (100)

1. Agardh D, Lynch K, Brundin C et al (2006) Reduction of tissue transglutaminase autoantibody levels by gluten-free diet is associated with changes in subsets of peripheral blood lymphocytes in children with newly diagnosed coeliac disease. Clin Exp Immunol 144:67-75
2. Ahonen P, Myllarniemi S, Sipila I et al (1990) Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 322:1829-1836
3. Aleman K, Noordzij JG, de Groot R et al (2001) Reviewing Omenn syndrome. Eur J Pediatr 160:718-725
4. Anderson MS, Venanzi ES, Klein L et al (2002) Projection of an immunological self shadow within the thymus by the aire protein. Science 298:1395-1401
5. Asano M, Toda M, Sakaguchi N et al (1996) Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 184:387-396
6. Balandina A, Lecart S, Dartevelle P et al (2005) Functional defect of regulatory CD4+CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. Blood 105:735-741
7. Battaglia A, Di Schino C, Fattorossi A et al (2005a) Circulating CD4+CD25+ T regulatory and natural killer T cells in patients with myasthenia gravis: a flow cytometry study. J Biol Regul Homeost Agents 19:54-62
8. Battaglia M, Stabilini A, Roncarolo MG (2005b) Rapamycin selectively expands CD4+CD25+FOXP3+ regulatory T cells. Blood 105(12):4743-4748
9. Baud O, Goulet O, Canioni D et al (2001) Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation. N Engl J Med 344:1758-1762
10. Bennett CL, Brunkow ME, Ramsdell F et al (2001) A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA→AAUGAA) leads to the IPEX syndrome. Immunogenetics 53:435-439
11. Bennett CL, Christie J, Ramsdell F et al (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27:20-21
12. Betterle C, Greggio NA, Volpato M (1998) Clinical review 93: autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab 83:1049-1055
13. Bindl L, Torgerson T, Perroni L et al (2005) Successful use of the new immune-suppressor sirolimus in IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome). J Pediatr 147:256-259
14. Bjorses P, Aaltonen J, Horelli-Kuitunen N et al (1998) Gene defect behind APECED: a new clue to autoimmunity. Hum Mol Genet 7:1547-1553
15. Bousvaros A, Leichtner AM, Book L et al (1996) Treatment of pediatric autoimmune enteropathy with tacrolimus (FK506). Gastroenterology 111:237-243
16. Boyer O, Saadoun D, Abriol J et al (2004) CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis. Blood 103:3428-3430
17. Brusko TM, Wasserfall CH, Clare-Salzler MJ et al (2005) Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes. Diabetes 54:1407-1414
18. Cavadini P, Vermi W, Facchetti F et al (2005) AIRE deficiency in thymus of 2 patients with Omenn syndrome. J Clin Invest 115:728-732
19. Chatila TA (2005) Role of regulatory T cells in human diseases. J Allergy Clin Immunol 116:949-959
20. Chatila TA, Blaeser F, Ho N et al (2000) JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 106:R75-R81
21. Coenen JJ, Koenen HJ, van Rijssen E et al (2006) Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells. Blood 107:1018-1023
22. Crispin JC, Martinez A, Alcocer-Varela J (2003) Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 21:273-276
23. De Benedetti F, Insalaco A, Diamanti A et al (2006) Mechanistic associations of a mild phenotype of immunodysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Clin Gastroenterol Hepatol 4:653-659
24. de Kleer IM, Wedderburn LR, Taams LS et al (2004) CD4 +CD25(bright) regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol 172:6435-6443
25. de Kleer I, Vastert B, Klein M et al (2006) Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network. Blood 107:1696-1702
26. Drappa J, Vaishnaw AK, Sullivan KE et al (1996) Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N Engl J Med 335:1643-1649
27. Dupuis-Girod S, Medioni J, Haddad E et al (2003) Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics 111:e622-e627
28. Ege M, Ma Y, Manfras B et al (2005) Omenn syndrome due to ARTEMIS mutations. Blood 105:4179-4186
29. Fattorossi A, Battaglia A, Buzzonetti A et al (2005) Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment. Immunology 116:134-141
30. Fisher GH, Rosenberg FJ, Straus SE et al (1995) Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935-946
31. Fontenot JD, Rudensky AY (2005) A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol 6:331-337
32. Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4:330-336
33. Fontenot JD, Rasmussen JP, Gavin MA et al (2005) A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 6:1142-1151
34. Furihata M, Sawada T, Okada T et al (2006) Total colectomy improves altered distribution of regulatory T cells in patients with ulcerative colitis. World J Surg 30:590-597
35. Furuno K, Yuge T, Kusuhara K et al (2004) CD25+CD4+ regulatory T cells in patients with Kawasaki disease. J Pediatr 145:385-390
36. Gambineri E, Torgerson TR, Ochs HD (2003) Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 15:430-435
37. Gavin MA, Torgerson TR, Houston E et al (2006) Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci USA 103:6659-6664
38. Giannouli S, Anagnostou D, Soliotis F et al (2004) Autoimmune manifestations in common variable immunodeficiency. Clin Rheumatol 23:449-452
39. Giliani S, Bonfim C, de Saint Basile G et al (2006) Omenn syndrome in an infant with IL7RA gene mutation. J Pediatr 148:272-274
40. Haas J, Hug A, Viehover A et al (2005) Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur J Immunol 35:3343-3352
41. Heino M, Peterson P, Sillanpaa N et al (2000) RNA and protein expression of the murine autoimmune regulator gene (Aire) in normal, RelB-deficient and in NOD mouse. Eur J Immunol 30:1884-1893
42. Hoglund P (2006) Induced peripheral regulatory T cells: the family grows larger. Eur J Immunol 36:264-266
43. Honig M, Schwarz K (2006) Omenn syndrome: a lack of tolerance on the background of deficient lymphocyte development and maturation. Curr Opin Rheumatol 18:383-388
44. Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057-1061
45. Huan J, Culbertson N, Spencer L et al (2005) Decreased FOXP3 levels in multiple sclerosis patients. J Neurosci Res 81:45-52
46. Iellem A, Colantonio L, D'Ambrosio D (2003) Skin-versus gut-skewed homing receptor expression and intrinsic CCR4 expression on human peripheral blood CD4+CD25+ suppressor T cells. Eur J Immunol 33:1488-1496
47. Kalman L, Lindegren ML, Kobrynski L et al (2004) Mutations in genes required for T-cell development: IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review. Genet Med 6:16-26
48. Kelsen J, Agnholt J, Hoffmann HJ et al (2005) FoxP3(+)CD4(+) CD25(+) T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease. Clin Exp Immunol 141:549-557
49. Khattri R, Cox T, Yasayko SA et al (2003) An essential role for scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4:337-342
50. Kobayashi I, Nakanishi M, Okano M et al (1995) Combination therapy with tacrolimus and betamethasone for a patient with X-linked auto-immune enteropathy. Eur J Pediatr 154:594-595
51. Kriegel MA, Lohmann T, Gabler C et al (2004) Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II. J Exp Med 199:1285-1291
52. Lan RY, Cheng C, Lian ZX et al (2006) Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology 43:729-737
53. Lawson CA, Brown AK, Bejarano V et al (2006) Early rheumatoid arthritis is associated with a deficit in the CD4+ CD25high regulatory T cell population in peripheral blood. Rheumatology (Oxford) DOI 10.1093/rheumatology/kel089
54. Lee JH, Wang LC, Lin YT et al (2006) Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Immunology 117:280-286
55. Lindley S, Dayan CM, Bishop A et al (2005) Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes 54:92-99
56. Liston A, Lesage S, Wilson J et al (2003) Aire regulates negative selection of organ-specific T cells. Nat Immunol 4:350-354
57. Liu MF, Wang CR, Fung LL et al (2004) Decreased CD4+CD25 + T cells in peripheral blood of patients with systemic lupus erythematosus. Scand J Immunol 59:198-202
58. Liu MF, Wang CR, Fung LL et al (2005) The presence of cytokine-suppressive CD4+CD25+ T cells in the peripheral blood and synovial fluid of patients with rheumatoid arthritis. Scand J Immunol 62:312-317
59. Longhi MS, Ma Y, Bogdanos DP et al (2004) Impairment of CD4+CD25+ regulatory T-cells in autoimmune liver disease. J Hepatol 41:31-37
60. Longhi MS, Hussain MJ, Mitry RR et al (2006) Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol 176:4484-4491
61. Makita S, Kanai T, Oshima S et al (2004) CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells. J Immunol 173:3119-3130
62. Mantel PY, Ouaked N, Ruckert B et al (2006) Molecular mechanisms underlying FOXP3 induction in human T cells. J Immunol 176:3593-3602
63. Marinaki S, Neumann I, Kalsch AI et al (2005) Abnormalities of CD4 T cell subpopulations in ANCA-associated vasculitis. Clin Exp Immunol 140:181-191
64. Maul J, Loddenkemper C, Mundt P et al (2005) Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. Gastroenterology 128:1868-1878
65. Mazzolari E, Forino C, Fontana M et al (2005) A new case of IPEX receiving bone marrow transplantation. Bone Marrow Transplant 35:1033-1034
66. McGinness JL, Bivens MM, Greer KE et al (2006) Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) associated with pemphigoid nodularis: a case report and review of the literature. J Am Acad Dermatol 55:143-148
67. Miyara M, Amoura Z, Parizot C et al (2006) The immune paradox of sarcoidosis and regulatory T cells. J Exp Med 203:359-370
68. Möttönen M, Heikkinen J, Mustonen L et al (2005) CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol 140:360-367
69. Nieves DS, Phipps RP, Pollock SJ et al (2004) Dermatologic and immunologic findings in the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Arch Dermatol 140:466-472
70. Ochs HD, Notarangelo LD (2005) Structure and function of the Wiskott-Aldrich syndrome protein. Curr Opin Hematol 12:284-291
71. Park O, Grishina I, Leung PS et al (2005) Analysis of the foxp3/scurfin gene in Crohn's disease. Ann N Y Acad Sci 1051:218-228
72. Putnam AL, Vendrame F, Dotta F et al (2005) CD4+CD25high regulatory T cells in human autoimmune diabetes. J Autoimmun 24:55-62
73. Randolph DA, Fathman CG (2006) CD4+CD25+ regulatory T cells and their therapeutic potential. Annu Rev Med 57:381-402
74. Rieux-Laucat F, Le Deist F, Hivroz C et al (1995) Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347-1349
75. Rieux-Laucat F, Le Deist F, Fischer A (2003) Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways. Cell Death Differ 10:124-133
76. Roifman CM (2000) Human IL-2 receptor alpha chain deficiency. Pediatr Res 48:6-11
77. Roncador G, Brown PJ, Maestre L et al (2005) Analysis of FOXP3 protein expression in human CD4(+)CD25(+) regulatory T cells at the single-cell level. Eur J Immunol 35:1681-1691
78. Ruprecht CR, Gattorno M, Ferlito F et al (2005) Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia. J Exp Med 201:1793-1803
79. Ryan KR, Lawson CA, Lorenzi AR et al (2005) CD4+CD25+ T-regulatory cells are decreased in patients with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy. J Allergy Clin Immunol 116:1158-1159
80. Sakaguchi S, Sakaguchi N, Asano M et al (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155:1151-1164
81. Schwartz RH (2005) Natural regulatory T cells and self-tolerance. Nat Immunol 6:327-330
82. Setoguchi R, Hori S, Takahashi T et al (2005) Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med 201:723-735
83. Sharfe N, Dadi HK, Shahar M et al (1997) Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor. Proc Natl Acad Sci USA 94:3168-3171
84. Sun Y, Qiao J, Lu CZ et al (2004) Increase of circulating CD4+ CD25+ T cells in myasthenia gravis patients with stability and thymectomy. Clin Immunol 112:284-289
85. Suri-Payer E, Amar AZ, Thornton AM et al (1998) CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 160:1212-1218
86. Takahashi T, Kuniyasu Y, Toda M et al (1998) Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 10:1969-1980
87. Takahashi M, Nakamura K, Honda K et al (2006) An inverse correlation of human peripheral blood regulatory T cell frequency with the disease activity of ulcerative colitis. Dig Dis Sci 51:677-686
88. van Amelsfort JM, Jacobs KM, Bijlsma JW et al (2004) CD4(+) CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum 50:2775-2785
89. Venken K, Hellings N, Hensen K et al (2006) Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4(+)CD25(+) regulatory T-cell function and FOXP3 expression. J Neurosci Res 83:1432-1446
90. Verhagen J, Akdis M, Traidl-Hoffmann C et al (2006) Absence of T-regulatory cell expression and function in atopic dermatitis skin. J Allergy Clin Immunol 117:176-183
91. Viglietta V, Baecher-Allan C, Weiner HL et al (2004) Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 199:971-979
92. Vogel A, Strassburg CP, Obermayer-Straub P et al (2002) The genetic background of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy and its autoimmune disease components. J Mol Med 80:201-211
93. Vukmanovic-Stejic M, McQuaid A, Birch KE et al (2005) Relative impact of CD4+CD25+ regulatory T cells and tacrolimus on inhibition of T-cell proliferation in patients with atopic dermatitis. Br J Dermatol 153:750-757
94. Walker MR, Kasprowicz DJ, Gersuk VH et al (2003) Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J Clin Invest 112:1437-1443
95. Wildin RS, Freitas A (2005) IPEX and FOXP3: clinical and research perspectives. J Autoimmun 25(Suppl):56-62
96. Wildin RS, Ramsdell F, Peake J et al (2001) X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27:18-20
97. Wildin RS, Smyk-Pearson S, Filipovich AH (2002) Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 39:537-545
98. Willerford DM, Chen J, Ferry JA et al (1995) Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3:521-530
99. Yagi H, Nomura T, Nakamura K et al (2004) Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol 16:1643-1656
100. Zlotogora J, Shapiro MS (1992) Polyglandular autoimmune syndrome type I among Iranian Jews. J Med Genet 29:824-826